Latest raise
$58M
Date raised
October 6, 2026
Round
Series A
InvestorsBioGeneration Ventures, Angelini Ventures, Kurma Partners
Websitewww.rougetx.com
About Jérémy Thalgott
a provider of first-in-class disease-modifying therapies designed to restore vascular integrity
- Who is Jérémy Thalgott?
- Jérémy Thalgott is listed as Co-founder of Rouge Therapeutics, a biotechnology company.
- How much did Rouge Therapeutics raise?
- Rouge Therapeutics raised $58M in a Series A round on October 6, 2026 (27 days ago). Backed by BioGeneration Ventures, Angelini Ventures, Kurma Partners.
Get newly funded founders every week
A free weekly list of startups that just raised.